{"AllianceGenome": "7133", "HGNC": "7133", "MIM": "602113", "_id": "8085", "_version": 2, "accession": {"genomic": ["AC011603.37", "CH471111.1", "CP068266.2", "MF155018.1", "NC_000012.12", "NC_060936.1", "NG_027827.1"], "protein": ["AAB91448.1", "AAC51734.1", "AAC51735.1", "AAH39197.1", "AWB97128.1", "BAD92731.1", "CAA69593.1", "EAW58034.1", "EAW58035.1", "EAW58036.1", "NP_003473.3", "O14686.2"], "rna": ["AB209494.1", "AF010403.1", "AF010404.1", "AL359940.1", "AW997729.1", "BC039197.2", "BC040663.2", "BF739070.1", "BF876885.1", "BF993837.1", "BI031059.1", "BX956541.1", "CR749712.1", "NM_003482.4", "U80756.1", "X85325.1", "Y08267.1"], "translation": [{"protein": "CAA69593.1", "rna": "Y08267.1"}, {"protein": "BAD92731.1", "rna": "AB209494.1"}, {"protein": "AAH39197.1", "rna": "BC039197.2"}, {"protein": "NP_003473.3", "rna": "NM_003482.4"}, {"protein": "AAB91448.1", "rna": "U80756.1"}, {"protein": "AAC51734.1", "rna": "AF010403.1"}, {"protein": "AAC51735.1", "rna": "AF010404.1"}]}, "alias": ["AAD10", "ALR", "BCAHH", "CAGL114", "KABUK1", "KMS", "MLL2", "MLL4", "TNRC21"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2021-10-21T14:55:01.022Z", "disease_label": "Kabuki syndrome 1", "gcep": "SCID-CID Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0007843", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_15029985-0c1a-4835-95fe-eb05dedaf85c-2021-10-21T145501.022Z", "sop": "SOP8"}}, "ec": "2.1.1.364", "ensembl": {"gene": "ENSG00000167548", "protein": ["ENSP00000301067", "ENSP00000497218", "ENSP00000506726", "ENSP00000507433", "ENSP00000508613", "ENSP00000508640", "ENSP00000508680", "ENSP00000508711", "ENSP00000508812", "ENSP00000508893", "ENSP00000508906", "ENSP00000509018", "ENSP00000509037", "ENSP00000509151", "ENSP00000509185", "ENSP00000509196", "ENSP00000509290", "ENSP00000509386", "ENSP00000509666", "ENSP00000509839", "ENSP00000509842", "ENSP00000510007", "ENSP00000510037", "ENSP00000510146", "ENSP00000510624"], "transcript": ["ENST00000301067", "ENST00000549743", "ENST00000550356", "ENST00000552391", "ENST00000650290", "ENST00000681974", "ENST00000682693", "ENST00000682886", "ENST00000683043", "ENST00000683543", "ENST00000683863", "ENST00000684428", "ENST00000684755", "ENST00000685024", "ENST00000685166", "ENST00000685554", "ENST00000685979", "ENST00000685982", "ENST00000686151", "ENST00000686564", "ENST00000686968", "ENST00000687201", "ENST00000687241", "ENST00000688095", "ENST00000688411", "ENST00000689060", "ENST00000689143", "ENST00000689944", "ENST00000691463", "ENST00000691932", "ENST00000691986", "ENST00000692465", "ENST00000692637", "ENST00000692841", "ENST00000692973"], "translation": [{"protein": "ENSP00000506726", "rna": "ENST00000683543"}, {"protein": "ENSP00000509037", "rna": "ENST00000691932"}, {"protein": "ENSP00000509185", "rna": "ENST00000685024"}, {"protein": "ENSP00000301067", "rna": "ENST00000301067"}, {"protein": "ENSP00000507433", "rna": "ENST00000684428"}, {"protein": "ENSP00000509386", "rna": "ENST00000685166"}, {"protein": "ENSP00000509666", "rna": "ENST00000692637"}, {"protein": "ENSP00000510146", "rna": "ENST00000688411"}, {"protein": "ENSP00000510624", "rna": "ENST00000691463"}, {"protein": "ENSP00000509842", "rna": "ENST00000687241"}, {"protein": "ENSP00000508906", "rna": "ENST00000685979"}, {"protein": "ENSP00000509290", "rna": "ENST00000686564"}, {"protein": "ENSP00000509196", "rna": "ENST00000691986"}, {"protein": "ENSP00000508893", "rna": "ENST00000692973"}, {"protein": "ENSP00000508613", "rna": "ENST00000685982"}, {"protein": "ENSP00000508640", "rna": "ENST00000685554"}, {"protein": "ENSP00000508711", "rna": "ENST00000692841"}, {"protein": "ENSP00000510037", "rna": "ENST00000687201"}, {"protein": "ENSP00000509839", "rna": "ENST00000689143"}, {"protein": "ENSP00000508812", "rna": "ENST00000689944"}, {"protein": "ENSP00000509018", "rna": "ENST00000689060"}, {"protein": "ENSP00000497218", "rna": "ENST00000650290"}, {"protein": "ENSP00000510007", "rna": "ENST00000688095"}, {"protein": "ENSP00000509151", "rna": "ENST00000686968"}, {"protein": "ENSP00000508680", "rna": "ENST00000692465"}], "type_of_gene": "protein_coding"}, "entrezgene": "8085", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 137.618666912, "exp_mis": 1842.90559992, "exp_syn": 792.880172511, "lof_z": 10.6917486700098, "mis_z": 3.09801602446164, "mu_lof": 1.16512751367e-05, "mu_mis": 0.000177614355119, "mu_syn": 7.52359137163e-05, "n_lof": 11.0, "n_mis": 1571.0, "n_syn": 919.0, "p_li": 0.999999999999995, "p_null": 8.78426426981725e-44, "p_rec": 5.39357356800153e-15, "syn_z": -2.77670023873341}, "bp": 16614, "cds_end": 49449107, "cds_start": 49415562, "n_exons": 54, "nonpsych": {"exp_lof": 123.566000645, "exp_mis": 1667.0152804, "exp_syn": 716.640986607, "lof_z": 9.94511111567764, "mis_z": 3.28623082853147, "mu_lof": 1.16512751367e-05, "mu_mis": 0.000177614355119, "mu_syn": 7.52359137163e-05, "n_lof": 11.0, "n_mis": 1401.0, "n_syn": 828.0, "p_li": 0.999999999999097, "p_null": 2.79361647003418e-38, "p_rec": 9.02541908973645e-13, "syn_z": -2.61901511649011}, "nontcga": {"exp_lof": 126.512468998, "exp_mis": 1695.37656636, "exp_syn": 729.353174873, "lof_z": 10.2184959973118, "mis_z": 3.11419463129359, "mu_lof": 1.16512751367e-05, "mu_mis": 0.000177614355119, "mu_syn": 7.52359137163e-05, "n_lof": 10.0, "n_mis": 1438.0, "n_syn": 831.0, "p_li": 0.999999999999937, "p_null": 1.75061073650905e-40, "p_rec": 6.3375584095551e-14, "syn_z": -2.38312591986785}, "transcript": "ENST00000301067.7"}, "exons": [{"cdsend": 49055324, "cdsstart": 49021779, "chr": "12", "position": [[49018977, 49021872], [49022042, 49022151], [49022279, 49022353], [49022589, 49022875], [49024577, 49024708], [49024809, 49024946], [49026181, 49027322], [49027802, 49027930], [49028008, 49028141], [49028827, 49028958], [49029060, 49029236], [49029400, 49029476], [49030279, 49030439], [49030600, 49030768], [49030892, 49031033], [49031174, 49033964], [49034066, 49034299], [49034409, 49034476], [49034581, 49034666], [49034811, 49034935], [49037124, 49038989], [49039221, 49039358], [49039434, 49039617], [49039723, 49041535], [49041654, 49041705], [49041916, 49041990], [49042088, 49042330], [49042560, 49042645], [49042740, 49042878], [49043075, 49043186], [49043362, 49043428], [49043634, 49043782], [49043867, 49043998], [49044199, 49044304], [49044402, 49044522], [49044743, 49044965], [49045919, 49045967], [49046064, 49046174], [49046259, 49046424], [49046608, 49046790], [49047964, 49048069], [49048658, 49048769], [49049104, 49049218], [49049681, 49050790], [49050885, 49052424], [49052563, 49052709], [49052914, 49053072], [49053206, 49053321], [49053475, 49053641], [49053977, 49054140], [49054306, 49054416], [49054527, 49054751], [49054899, 49055026], [49055275, 49055361], [49059612, 49060794]], "strand": -1, "transcript": "NM_003482", "txend": 49060794, "txstart": 49018977}], "exons_hg19": [{"cdsend": 49449107, "cdsstart": 49415562, "chr": "12", "position": [[49412760, 49415655], [49415825, 49415934], [49416062, 49416136], [49416372, 49416658], [49418360, 49418491], [49418592, 49418729], [49419964, 49421105], [49421585, 49421713], [49421791, 49421924], [49422610, 49422741], [49422843, 49423019], [49423183, 49423259], [49424062, 49424222], [49424383, 49424551], [49424675, 49424816], [49424957, 49427747], [49427849, 49428082], [49428192, 49428259], [49428364, 49428449], [49428594, 49428718], [49430907, 49432772], [49433004, 49433141], [49433217, 49433400], [49433506, 49435318], [49435437, 49435488], [49435699, 49435773], [49435871, 49436113], [49436343, 49436428], [49436523, 49436661], [49436858, 49436969], [49437145, 49437211], [49437417, 49437565], [49437650, 49437781], [49437982, 49438087], [49438185, 49438305], [49438526, 49438748], [49439702, 49439750], [49439847, 49439957], [49440042, 49440207], [49440391, 49440573], [49441747, 49441852], [49442441, 49442552], [49442887, 49443001], [49443464, 49444573], [49444668, 49446207], [49446346, 49446492], [49446697, 49446855], [49446989, 49447104], [49447258, 49447424], [49447760, 49447923], [49448089, 49448199], [49448310, 49448534], [49448682, 49448809], [49449058, 49449144], [49453395, 49454577]], "strand": -1, "transcript": "NM_003482", "txend": 49454577, "txstart": 49412760}], "generif": [{"pubmed": 16603732, "text": "suggests a central role for the MLL2 complex in the growth of ERalpha-positive cancer cells"}, {"pubmed": 17178841, "text": "Knockdown of MLL2 reveals ALR target genes and leads to alterations in cell adhesion and growth."}, {"pubmed": 18082152, "text": "CGBP interacts with MLL1, MLL2 as well as Set1 H3-Lysine 4 (H3K4) specific methyl-transferases and plays critical roles in regulations of MLL target genes."}, {"pubmed": 19219072, "text": "A molecular mechanism by which the recruitment of a H3K4 histone methyltransferase complex on the promoter of a NF-kappaB-dependent gene induces its expression."}, {"pubmed": 19221051, "text": "Study show that the C-terminal SET domain of MLL3 and MLL4 directly interacts with INI1, an integral subunit of Swi/Snf."}, {"pubmed": 19556342, "text": "ASCOM-MLL3 and ASCOM-MLL4 play redundant but essential roles in FXR transactivation via their histone 3 lysine 4 trimethylation activity."}, {"pubmed": 20711175, "text": "Mutations in MLL2 are major cause of Kabuki syndrome."}, {"pubmed": 20937768, "text": "Data show that Pygo2 associates with MLL2 histone methyltransferase and STAGA histone acetyltransferase to facilitate their interaction with beta-catenin and Wnt1-induced, TCF/LEF-dependent transactivation in breast cancer cells."}, {"pubmed": 21280141, "text": "Direct sequencing of all 54 exons of the MLL2 gene in 45 clinically well-defined Kabuki Syndrome patients identified 34 (75.6%) different mutations. One mutation has been described previously, all others are novel."}, {"pubmed": 21447625, "text": "The trimethylation of histone H3 at Lys 4 by the MLL2/MLL3 subunits of ASCOM, enhanced by the hormone-induced displacement of the H3K4 demethylase KDM5B, stabilizes NURF binding."}, {"pubmed": 21658225, "text": "a large spectrum of MLL2 mutations in patients with Kabuki syndrome"}, {"pubmed": 21671394, "text": "MLL2 mutations were found in 81/110 (74%) of Kabuki syndrome families"}, {"pubmed": 21683083, "text": "These studies demonstrated that HOXC6 is an estrogen-responsive gene, and that histone methylases MLL2 and MLL3, in coordination with ERalpha and ERbeta, transcriptionally regulate HOXC6 in an estrogen-dependent manner."}, {"pubmed": 21796119, "text": "32% of diffuse large B-cell lymphoma and 89% of follicular lymphoma cases had somatic mutations in MLL2, and 11.4% and 13.4% of DLBCL and FL cases, respectively, had mutations in MEF2B"}, {"pubmed": 22126750, "text": "phenotypic variability of Kabuki syndrome suggests that MLL2 testing should be considered even in atypical patients."}, {"pubmed": 22183980, "text": "No somatic mutations were identified in the PTCH1, MLL2, and MLL3 genes in our cohort of hepatoblastoma samples"}, {"pubmed": 22829784, "text": "we defined a role for Trithorax proteins WDR5 and MLL2 in activating the differentiation gene program in epidermal progenitor cells"}, {"pubmed": 22840376, "text": "Microdeletions and microduplications have not been identified in the MLL2 and KDM6A genes of a large cohort of patients with Kabuki syndrome."}, {"pubmed": 22901312, "text": "This study expands the known genetic basis of Kabuki syndrome (KS) by showing mosaic mutations and large intragenic deletions and duplications of MLL2 in patients with KS."}, {"pubmed": 23045699, "text": "results present a genome-wide integrative analysis of the MLL2 target loci and suggest potential mechanisms underlying tumorigenesis driven by MLL2 alterations"}, {"pubmed": 23129768, "text": "the second PHD finger (PHD2) of MLL1 is an E3 ubiquitin ligase in the presence of the E2-conjugating enzyme CDC34. This activity is conserved in the second PHD finger of MLL4, the closest homolog to MLL1 but not in MLL2 or MLL3."}, {"pubmed": 23130995, "text": "Studies suggest the KMT2D (MLL2) nomenclature as H3K4 methyltransferases."}, {"pubmed": 23131014, "text": "Studies indicate that mutation screening confirmed KMT2D (MLL2) as the major causative gene for Kabuki syndrome (KS)."}, {"pubmed": 23184418, "text": "MLL2 mutations occur in a subgroup-independent manner."}, {"pubmed": 23192982, "text": "MLL1 and MLL2 bind to SR-B1 promoter in an E2-dependent manner and control the assembly of transcription pre-initiation complex and RNA polymerase II recruitment."}, {"pubmed": 23320472, "text": "MLL2 mutation positive patients have a more severe and typical Kabuki phenotype than the MLL2 mutation negative group."}, {"pubmed": 23754336, "text": "these results indicate that the suppression of MLL genes, especially MLL2 and MLL5, take part in modulating breast carcinogenesis."}, {"pubmed": 23913813, "text": "The identification of novel MLL2 mutations in patients with Kabuki syndrome."}, {"pubmed": 23995757, "text": "Ectopic AKAP95 stimulates expression of a chromosomal reporter gene in synergy with MLL1 or MLL2, whereas AKAP95 depletion impairs retinoic acid-mediated gene induction in embryonic stem cells"}, {"pubmed": 24081332, "text": "MLL3 and MLL4 function in the regulation of enhancer activity."}, {"pubmed": 24240169, "text": "Study supports that KMT2D has distinct roles in neoplastic cells, as opposed to normal cells."}, {"pubmed": 24323028, "text": "Data indicate that seven genes showed statistical enrichment for mutation: TP53, RB1, PTEN, NFE2L2, KEAP1, MLL2, and PIK3CA."}, {"pubmed": 24368734, "text": "Identify MLL4 as a major mammalian H3K4 mono- and di-methyltransferase essential for enhancer activation during cell differentiation."}, {"pubmed": 24368734, "text": "MLL4 (KMT2D) is a major H3K4 mono- and di-methyltransferase with partial functional redundancy with MLL3 (KMT2C) in mouse and human cells. MLL4 is enriched on enhancers and is required for enhancer activation, cell-type-specific gene expression and cell differentiation."}, {"pubmed": 24368734, "text": "MLL4 (KMT2D) is a major H3K4 mono- and di-methyltransferase with partial functional redundancy with MLL3 (KMT2C) in mouse and human cells. MLL4 is enriched on enhancers and is required for enhancer activation, cell-type-specific gene expression and cell differentiation."}, {"pubmed": 24491801, "text": "High levels of UTX or MLL4 are associated with poor prognosis in patients with breast cancer."}, {"pubmed": 24705355, "text": "Like KMT2D, CHD7 interacts with members of the WAR complex, namely WDR5, ASH2L and RbBP5. We therefore propose that CHD7 and KMT2D function in the same chromatin modification machinery."}, {"pubmed": 24739679, "text": "10 out of the 11 mutations found in patients with Kabuki syndrome were novel. KMT2D mutations included four small deletions or insertions and four nonsense and two missense mutations."}, {"pubmed": 25112956, "text": "Reduced or lost expression of MLL2 was commonly observed in tumor tissues as compared with paired adjacent non-tumor tissues regardless of mutation status."}, {"pubmed": 25123191, "text": "Data identified mutations in epigenetic modifiers such as KMT2D as potential early driving events in lymphomagenesis and immune escape alterations as relapse-associated events in diffuse large B-cell lymphoma."}, {"pubmed": 25281733, "text": "Mutations in KMT2D gene were identified in 10/16 (62%) of the patients, whereas none of the patients had KDM6A mutations."}, {"pubmed": 25355294, "text": "Results from targeted sequencing in patients with acute lymphoblastic leukemia identified KMT2D and KIF1B as novel putative driver genes and a putative regulatory non-coding variant that coincided with overexpression of the growth factor MDK."}, {"pubmed": 25944076, "text": "We have reported a female Kabuki syndrome patient with typical dysmorphic features and developmental delay and a novel KMT2D mutation."}, {"pubmed": 25972376, "text": "Our results provide further support for the similar roles of KMT2D and KDM6A in the etiology of KS by using a vertebrate model organism to provide direct evidence of their roles in the development of organs and tissues affected in KS patients."}, {"pubmed": 26032282, "text": "KMT2D represents a recurrently mutated gene with potential implication for pheochromocytoma development."}, {"pubmed": 26049589, "text": "Kabuki syndrome may be caused by mutations in one of two histone methyltransferase genes: KMT2D and KDM6A."}, {"pubmed": 26138514, "text": "Mutations in MLL2 are present in approximately 27% of urothelial carcinoma cases ."}, {"pubmed": 26194542, "text": "In patients with Kabuki Syndrome, autosomal dominant KMT2D mutations are associated with dysregulation of terminal B-cell differentiation, leading to humoral immune deficiency and, in some cases, autoimmunity."}, {"pubmed": 26290144, "text": "The results do not support our hypothesis that common germline genetic variants in the MLL2 genes is associated with the risk of developing medulloblastoma."}, {"pubmed": 26303934, "text": "Data suggest that lysine methyltransferase 2D (KMT2D) mutations are rare in abdominal paraganglioma (PGLs)."}, {"pubmed": 26366710, "text": "KMT2D mutations may promote malignant outgrowth by perturbing the expression of tumor suppressor genes that control B cell-activating pathways"}, {"pubmed": 26366712, "text": "findings suggest that KMT2D acts as a tumor suppressor gene whose early loss facilitates lymphomagenesis by remodeling the epigenetic landscape of the cancer precursor cells"}, {"pubmed": 26551667, "text": "Mutations in KMT2D gene is associated with cutaneous T cell lymphoma and Sezary syndrome."}, {"pubmed": 26711341, "text": "Whereas Set1 targets are largely associated with the maintenance of the stem cell population, MLL1/2 targets are specifically enriched for genes involved in ciliogenesis."}, {"pubmed": 26722499, "text": "Our data suggest that MLL2 protein is overexpressed in primary gastrointestinal diffuse large B cell lymphoma and appears as a prognostic factor"}, {"pubmed": 26757828, "text": "Mutation in the MLL2 gene is associated with Kabuki Syndrome."}, {"pubmed": 26841698, "text": "high proportion of recurrent somatic DICER1 and KMT2D mutations in this series of sporadic IO-MEPL points to their likely important roles in the molecular pathogenesis of these rare embryonal tumors"}, {"pubmed": 26841933, "text": "Pathogenic variants in KMT2D resulting in protein truncation in 43% (6/14; of which 3 are novel) of all cases were detected, while analysis of KDM6A was negative. MLPA analysis was negative in all instances."}, {"pubmed": 26898171, "text": "Mutations of the epigenetic genes KMT2D and KDM6A cause dysregulation of certain developmental genes and account for the multiple congenital anomalies of the syndrome"}, {"pubmed": 26902498, "text": "Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment."}, {"pubmed": 27280393, "text": "we demonstrate that low KMT2C and KMT2D expression in biopsies defines better outcome groups in pancreatic ductal adenocarcinoma"}, {"pubmed": 27302555, "text": "Study reports mutation screening in patients with Kabuki Syndrome Subtype 2 (KS2), in which 12 novel KDM6A mutations are identified. These results confirm that female patients with KS2 may have a rather mild manifestation of KS and may even develop normally with regard to cognitive function."}, {"pubmed": 27387124, "text": "Mutations of ARID1A, GPRC5A and MLL2 grant bladder cancer non-stem cells the capability of self-renewal."}, {"pubmed": 27530205, "text": "A possible correlation between the position of the KMT2D premature termination codon caused by the mutation and height SDS was assessed, but a significant difference could not be observed for the Kabuki syndrome patients"}, {"pubmed": 27566587, "text": "analysis of highly recurrent genetic lesions in components of the NF-kappaB pathway, of NOTCH1 and NOTCH2 as well as KMT2D that may have a role in ocular adnexal MALT-type marginal zone lymphomas"}, {"pubmed": 27632392, "text": "We identify three mosaic missense and likely-gene disrupting mutations in genes previously implicated in ASD (KMT2C, NCKAP1, and MYH10) in probands but none in siblings. We find a strong ascertainment bias for mosaic mutations in probands relative to their unaffected siblings"}, {"pubmed": 27698142, "text": "Although enhancer priming by MLL4/KMT2D is dispensable for cell-identity maintenance in mouse, it controls cell fate transition by orchestrating p300-mediated enhancer activation"}, {"pubmed": 27749841, "text": "KMT2D Mutation is associated with esophageal squamous cell carcinoma."}, {"pubmed": 27991736, "text": "KMT2D p.Gln3575His segregated with disease status in the family, and is associated with a unique and conserved phenotype in the affected family members, with features overlapping with Kabuki and CHARGE syndromes. Our findings further support the potential etiological link between these two classically distinct conditions."}, {"pubmed": 28007623, "text": "KMT2D mutation is associated with small Cell Lung Cancer."}, {"pubmed": 28013028, "text": "The enzymatic activity of H3K4 methyltransferase MLL4 is required for its protein stability."}, {"pubmed": 28157506, "text": "Study shows the contribution of MLL2's methyltransferase and CXXC domain in the trimethylation of H3K4 in embryonic stem cells and find that while it trimethylates H3K4 at both bivalent gene promoters and non-TSS elements, it regulates transcription at a limited number of genes including those required for primordial germ cell specification."}, {"pubmed": 28256057, "text": "Two patients' presentation of Kabuki syndrome has been described caused by different KMT2D mutations, both including an interrupted/bipartite clavicle."}, {"pubmed": 28336670, "text": "data support akey role forKMT2D in modulating the chromatin competence necessary for the assembly of the ER-FOXA1-PBX1 transcriptional regulatory network in breast cancer."}, {"pubmed": 28390392, "text": "Results highlight the emerging role of mutations in epigenetic regulators, particularly MLL2, in cervical carcinogenesis, which suggests a potential disruption of histone modifications."}, {"pubmed": 28475860, "text": "Our findings provide evidence that CHARGE and Kabuki syndromes result from dysregulatrion of CHD7 and KMT2D genes involved embryonal development that are expressed in a tissue-specific manner."}, {"pubmed": 28590022, "text": "The uniqueness of our case is the sporadic co-occurrence of two genetic disorders, that is, a de novo frameshift variant in the KMT2D gene and a de novo 3.2 Mbp 10q22.3q23.1 deletion."}, {"pubmed": 28609655, "text": "MLL1 and MLL2 collaborate to regulate gene expression and leukemia maintenance not through redundancy, but through distinct pathways."}, {"pubmed": 28805986, "text": "Three of four cases of histiocytic sarcoma had alterations in the KMT2D gene."}, {"pubmed": 28884922, "text": "a congenital heart defects (CHD)is detected in 70% of patients with KMT2D (MLL2) pathogenic variants, most commonly left-sided obstructive lesions, including multiple left-sided obstructions similar to those observed in the spectrum of the Shone complex, and septal defects."}, {"pubmed": 29265349, "text": "The results suggest therefore that KMT2D mutations may help to diagnose CAD and better distinguish it from lymphoplasmacytic lymphoma."}, {"pubmed": 29269867, "text": "KMT2D epigenetically activates PI3K/Akt pathway and epithelial-mesenchymal transition by targeting LIFR and KLF4 and thus serves as a putative epigenetic-based target for treating Prostate cancer."}, {"pubmed": 29283410, "text": "Clinical and neurobehavioral features of three novel Kabuki Syndrome unrelated patients with mosaic KMT2D mutations have been described."}, {"pubmed": 29305415, "text": "enhancing the interaction of KMT2D with the transcription factor PU.1, thereby inactivating the H3K4me-associated signaling pathway MAPK, which is constitutively activated in T-cell lymphoma"}, {"pubmed": 29440247, "text": "results reveal a critical role for KMT2D in the control of epithelial enhancers and p63 target gene expression, including the requirement of KMT2D for the maintenance of epithelial progenitor gene expression and the coordination of proper terminal differentiation."}, {"pubmed": 29532228, "text": "Results indicate that overexpression of MLL2 predicts poor clinical outcomes and facilitates ESCC tumor progression, and it may exert oncogenic role via activation of EMT."}, {"pubmed": 29627316, "text": "The KMT2D mutation was associated with reduced survival in non-small-cell lung cancer but not in small cell lung cancer"}, {"pubmed": 29807113, "text": "mutations in KMT2D, which are common in many cancers, correlate with drug sensitivity in two independent datasets"}, {"pubmed": 29907798, "text": "we retrospectively evaluated 100 infants with HI lacking a genetic diagnosis, for causative variants in KS genes.  Molecular diagnoses of KS were established by identification of pathogenic variants in KMT2D (n = 5) and KDM6A (n = 4)."}, {"pubmed": 29914387, "text": "This is a case of a mutation in the KMT2D gene in a girl with Kabuki syndrome."}, {"pubmed": 29950560, "text": "Study findings identify KMT2D inactivation as a novel driver event in adult-type granulosa cell tumors of the ovary and suggest that mutation of this gene may increase the risk of disease recurrence."}, {"pubmed": 30107592, "text": "The mutation pattern of KMT2D and KDM6A in a cohort of 505 patients clinically diagnosed as Kabuki syndrome was reported. The functional role of a subset of KMT2D missense mutations in impairing the protein enzymatic activity was demonstrated."}, {"pubmed": 30177394, "text": "KMT2D modulates proliferation and apoptosis of gastric cancer"}, {"pubmed": 30213761, "text": "A novel loss-of-function mutation was identified in a patient with Kabuki syndrome and systemic lupus erythematosus."}, {"pubmed": 30459467, "text": "KMT2D missense mutation is associated with Kabuki syndrome and cancers."}, {"pubmed": 30556359, "text": "Three of the 27 children had a KDM6A mutation and had thesame hypermobility as the KMT2D subjects. Only one of the Kabuki syndrome chil-dren had a patellar luxation in here previous history and was not con-sidered hypermobile using both scores."}, {"pubmed": 30984543, "text": "Comparison of the mRNA and miRNA expression profiles of mutated and wild-type KMT2D suggested that two signaling pathways (FOX1-miR-1224-5p-DLK1 and HIF/GATA5-miR-133a-3p-DRD5) may mediate the tumor suppressive effect of the KMT2D mutation."}, {"pubmed": 30990809, "text": "This work describes epigenetic modulating genes which are found to be mutated in breast cancer. Identified is the histone methyltransferase KMT2D, which is mutated in 6% of triple negative tumors and linked with poor survival."}, {"pubmed": 31123786, "text": "The most frequently mutated driver genes in our cohort were TP53 (involved in cell cycle control), FAT1 (Wnt signalling, cell-cell contacts, migration) and KMT2D.However, somatic mutations in FAT1 and smaller primary tumour volumes were associated with reduced radiomic intra-tumour heterogeneity."}, {"pubmed": 31127101, "text": "Nuclear magnetic resonance study identifies the PHD6 finger of MLL4 (MLL4-PHD6) as histone reader that exhibits high selectivity toward H4K16ac."}, {"pubmed": 31232159, "text": "Knockdown of KMT2D sensitized cells to DNA damage through the disturbance of antioxidative gene expression."}, {"pubmed": 31311407, "text": "Somatic mutations in KMT2D and TET2 associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders."}, {"pubmed": 31465303, "text": "Precocious neuronal differentiation and disrupted oxygen responses in Kabuki syndrome."}, {"pubmed": 31529049, "text": "we show that the nuclear PASK associates with the mammalian H3K4 MLL2 methyltransferase complex and enhances H3K4 di- and tri-methylation. We also show that PASK is a histone kinase that phosphorylates H3 at T3, T6, S10 and T11."}, {"pubmed": 31537689, "text": "KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study."}, {"pubmed": 31547991, "text": "MiRNA-217 accelerates proliferative and migratory abilities in bladder cancer via inhibiting the level of tumor suppressor KMT2D, thereafter leading to the poor prognosis in bladder cancer patients"}, {"pubmed": 31654559, "text": "Prenatal and perinatal history in Kabuki Syndrome."}, {"pubmed": 31676369, "text": "MLL2 promotes cancer cell lymph node metastasis by interacting with RelA and facilitating STC1 transcription."}, {"pubmed": 31846209, "text": "Holoprosencephaly in Kabuki syndrome."}, {"pubmed": 31876365, "text": "Growth charts in Kabuki syndrome 1."}, {"pubmed": 31883305, "text": "The phenotypic spectrum of Kabuki syndrome in patients of Chinese descent: A case series."}, {"pubmed": 31924266, "text": "KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies."}, {"pubmed": 31935506, "text": "This study expands the number of naturally occurring KMT2D and KDM6A variants. The discovery of novel pathogenic variants will add to the knowledge on disease-causing variants and the relevance of missense variants in Kabuki syndrome."}, {"pubmed": 31949313, "text": "A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndrome."}, {"pubmed": 32024448, "text": "Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in APC, BRAF, and KTM2D."}, {"pubmed": 32064880, "text": "KMT2D and TP53 mutation status improve the prognostic value of the International Prognostic Index (IPI) stratification in ENKTL patients."}, {"pubmed": 32083401, "text": "Phenotypic expansion of KMT2D-related disorder: Beyond Kabuki syndrome."}, {"pubmed": 32139118, "text": "MLL2 regulates glucocorticoid receptor-mediated transcription of ENACalpha in human retinal pigment epithelial cells."}, {"pubmed": 32243837, "text": "KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer."}, {"pubmed": 32350066, "text": "FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells."}, {"pubmed": 32525229, "text": "Kabuki syndrome with midgut malrotation and hyperinsulinemic hypoglycemia: A rare co-occurrence from Thailand."}, {"pubmed": 32668765, "text": "Loss of Function of the Gene Encoding the Histone Methyltransferase KMT2D Leads to Deregulation of Mitochondrial Respiration."}, {"pubmed": 32697937, "text": "Crystal Structure of MLL2 Complex Guides the Identification of a Methylation Site on P53 Catalyzed by KMT2 Family Methyltransferases."}, {"pubmed": 32738303, "text": "Identification of novel candidate genes in heterotaxy syndrome patients with congenital heart diseases by whole exome sequencing."}, {"pubmed": 32803813, "text": "Update of the genotype and phenotype of KMT2D and KDM6A by genetic screening of 100 patients with clinically suspected Kabuki syndrome."}, {"pubmed": 32878339, "text": "Merkel Cell Polyomavirus in Merkel Cell Carcinoma: Integration Sites and Involvement of the KMT2D Tumor Suppressor Gene."}, {"pubmed": 32988919, "text": "Predictive Role of TP53, PIK3CA and MLL2 in ER+ HER2+ Breast Bancer: Biomarker Analysis of Neo-ALL-IN [NCT 01275859]."}, {"pubmed": 33110216, "text": "Inhibition of Drp1 SUMOylation by ALR protects the liver from ischemia-reperfusion injury."}, {"pubmed": 33169020, "text": "MLL4-associated condensates counterbalance Polycomb-mediated nuclear mechanical stress in Kabuki syndrome."}, {"pubmed": 33314698, "text": "Clinical and molecular characterization study of Chinese Kabuki syndrome in Hong Kong."}, {"pubmed": 33402515, "text": "Low MLL2 Protein Expression Is Associated With Fibrosis in Early Stage Gastric Cancer."}, {"pubmed": 33483618, "text": "High incidence of MYD88 and KMT2D mutations in Chinese with chronic lymphocytic leukemia."}, {"pubmed": 33793001, "text": "KMT2D promotes proliferation of gastric cancer cells: evidence from ctDNA sequencing."}, {"pubmed": 34156443, "text": "The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape."}, {"pubmed": 34369642, "text": "Neuroimaging in Kabuki syndrome and another KMT2D-related disorder."}, {"pubmed": 34613626, "text": "Lysine methyltransferase 2D regulates muscle fiber size and muscle cell differentiation."}, {"pubmed": 34645806, "text": "Cancer gene mutation frequencies for the U.S. population."}, {"pubmed": 34933446, "text": "GRWD1-WDR5-MLL2 Epigenetic Complex Mediates H3K4me3 Mark and Is Essential for Kaposi's Sarcoma-Associated Herpesvirus-Induced Cellular Transformation."}, {"pubmed": 35060672, "text": "Refining the clinical phenotype associated with missense variants in exons 38 and 39 of KMT2D."}, {"pubmed": 35073341, "text": "Mutually exclusive mutation profiles define functionally related genes in muscle invasive bladder cancer."}, {"pubmed": 35189794, "text": "Pan-Cancer Analysis of Histone Methyltransferase KMT2D with Potential Implications for Prognosis and Immunotherapy in Human Cancer."}, {"pubmed": 35411950, "text": "USP7 sustains an active epigenetic program via stabilizing MLL2 and WDR5 in diffuse large B-cell lymphoma."}, {"pubmed": 35506254, "text": "Comparison of methylation episignatures in KMT2B- and KMT2D-related human disorders."}, {"pubmed": 35640156, "text": "Kabuki syndrome stem cell models reveal locus specificity of histone methyltransferase 2D (KMT2D/MLL4)."}, {"pubmed": 36395886, "text": "The SCF-FBXW7 E3 ubiquitin ligase triggers degradation of histone 3 lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage."}, {"pubmed": 36436503, "text": "Prenatal Phenotype of Kabuki Syndrome: Seven Case Series."}, {"pubmed": 36525973, "text": "KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition."}, {"pubmed": 36601880, "text": "Association of KMT2C/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer."}, {"pubmed": 36674608, "text": "Mutational Landscape of Bladder Cancer in Mexican Patients: KMT2D Mutations and chr11q15.5 Amplifications Are Associated with Muscle Invasion."}, {"pubmed": 36701842, "text": "MLL4 Regulates the Progression of Non-Small-Cell Lung Cancer by Regulating the PI3K/AKT/SOX2 Axis."}, {"pubmed": 36722273, "text": "KMT2D Regulates the NCOA6/THRB Signal Axis through Epigenetic Modification to Promote the Migration and Invasion of Papillary Thyroid Cancer."}, {"pubmed": 36893259, "text": "KMT2D acetylation by CREBBP reveals a cooperative functional interaction at enhancers in normal and malignant germinal center B cells."}, {"pubmed": 36924677, "text": "Histone methyltransferase KMT2D promotes prostate cancer progression through paracrine IL-6 signaling."}, {"pubmed": 37043208, "text": "Characterizing the molecular impact of KMT2D variants on the epigenetic and transcriptional landscapes in Kabuki syndrome."}, {"pubmed": 37140208, "text": "KMT2D links TGF-beta signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticity."}, {"pubmed": 37142882, "text": "KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition."}, {"pubmed": 37158694, "text": "Molecular insights of KMT2D and clinical aspects of Kabuki syndrome type 1."}, {"pubmed": 37410700, "text": "The KDM6A-KMT2D-p300 axis regulates susceptibility to diverse coronaviruses by mediating viral receptor expression."}, {"pubmed": 37550041, "text": "[Two novel and de novo KMT2D mutations on the same allele cause Kabuki syndrome]."}, {"pubmed": 37800171, "text": "SETting up the genome: KMT2D and KDM6A genomic function in the Kabuki syndrome craniofacial developmental disorder."}, {"pubmed": 37921229, "text": "Hearing characteristics and otoradiological abnormalities in three patients with novel pathogenic variants of KMT2D-related Kabuki syndrome."}, {"pubmed": 38015024, "text": "EBF2 Links KMT2D-Mediated H3K4me1 to Suppress Pancreatic Cancer Progression via Upregulating KLLN."}, {"pubmed": 38206414, "text": "Macular dystrophy in Kabuki syndrome due to de novo KMT2D variants: refining the phenotype with multimodal imaging and follow-up over 10 years: insight into pathophysiology."}, {"pubmed": 38254937, "text": "KMT2D Deficiency Causes Sensorineural Hearing Loss in Mice and Humans."}, {"pubmed": 38528056, "text": "DNA methylation profiling in Kabuki syndrome: reclassification of germline KMT2D VUS and sensitivity in validating postzygotic mosaicism."}, {"pubmed": 38684298, "text": "[Clinical and genetic characteristics of four children with Kabuki syndrome due to de novo variants of KMT2D gene]."}, {"pubmed": 39060071, "text": "Lysine Methyltransferase 2D Regulates Immune Response and Metastasis in Head and Neck Cancer."}], "genomic_pos": {"chr": "12", "end": 49060794, "ensemblgene": "ENSG00000167548", "start": 49018975, "strand": -1}, "genomic_pos_hg19": {"chr": "12", "end": 49453557, "start": 49412758, "strand": -1}, "go": {"BP": [{"evidence": "ISS", "gocategory": "BP", "id": "GO:0001555", "qualifier": "involved_in", "term": "oocyte growth"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0006355", "pubmed": 9247308, "qualifier": "involved_in", "term": "regulation of DNA-templated transcription"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0008284", "pubmed": 16603732, "qualifier": "involved_in", "term": "positive regulation of cell population proliferation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0031507", "qualifier": "involved_in", "term": "heterochromatin formation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032259", "qualifier": "involved_in", "term": "methylation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0033148", "pubmed": 16603732, "qualifier": "involved_in", "term": "positive regulation of intracellular estrogen receptor signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043627", "pubmed": 16603732, "qualifier": "involved_in", "term": "response to estrogen"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0045944", "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045944", "pubmed": [16603732, 35013237], "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048477", "qualifier": "involved_in", "term": "oogenesis"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:1904837", "qualifier": "involved_in", "term": "beta-catenin-TCF complex assembly"}], "CC": [{"evidence": "NAS", "gocategory": "CC", "id": "GO:0005634", "pubmed": 9247308, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0044666", "qualifier": "part_of", "term": "MLL3/4 complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0044666", "pubmed": 17500065, "qualifier": "part_of", "term": "MLL3/4 complex"}, {"evidence": "IPI", "gocategory": "CC", "id": "GO:0044666", "pubmed": 23508102, "qualifier": "part_of", "term": "MLL3/4 complex"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0000976", "pubmed": 16603732, "qualifier": "enables", "term": "transcription cis-regulatory region binding"}, {"category": "MF", "evidence": "NAS", "id": "GO:0003677", "pubmed": 9247308, "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0003713", "qualifier": "enables", "term": "transcription coactivator activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [15960975, 16603732, 17178841, 17500065, 22266653, 22665483, 22722839, 24981860, 26886794, 27705803, 33640491], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0042800", "qualifier": "enables", "term": "histone H3K4 methyltransferase activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0042800", "qualifier": "enables", "term": "histone H3K4 methyltransferase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0042800", "qualifier": "enables", "term": "histone H3K4 methyltransferase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046872", "qualifier": "enables", "term": "metal ion binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0140945", "qualifier": "enables", "term": "histone H3K4 monomethyltransferase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0140999", "qualifier": "enables", "term": "histone H3K4 trimethyltransferase activity"}]}, "homologene": {"genes": [[8364, 100494109], [9544, 710795], [9598, 100610362], [9606, 8085], [10090, 381022], [10116, 100362634]], "id": 86893}, "interpro": [{"desc": "High mobility group box domain", "id": "IPR009071", "short_desc": "HMG_box_dom"}, {"desc": "High mobility group box domain superfamily", "id": "IPR036910", "short_desc": "HMG_box_dom_sf"}, {"desc": "SET domain", "id": "IPR001214", "short_desc": "SET_dom"}, {"desc": "Zinc finger, RING-type", "id": "IPR001841", "short_desc": "Znf_RING"}, {"desc": "Zinc finger, PHD-type", "id": "IPR001965", "short_desc": "Znf_PHD"}, {"desc": "Post-SET domain", "id": "IPR003616", "short_desc": "Post-SET_dom"}, {"desc": "FY-rich, N-terminal", "id": "IPR003888", "short_desc": "FYrich_N"}, {"desc": "FY-rich, C-terminal", "id": "IPR003889", "short_desc": "FYrich_C"}, {"desc": "Zinc finger, FYVE/PHD-type", "id": "IPR011011", "short_desc": "Znf_FYVE_PHD"}, {"desc": "Zinc finger, RING/FYVE/PHD-type", "id": "IPR013083", "short_desc": "Znf_RING/FYVE/PHD"}, {"desc": "Zinc finger, PHD-finger", "id": "IPR019787", "short_desc": "Znf_PHD-finger"}, {"desc": "Extended PHD (ePHD) domain", "id": "IPR034732", "short_desc": "EPHD"}, {"desc": "KMT2D, SET domain", "id": "IPR037890", "short_desc": "SET_KMT2D"}, {"desc": "KMT2D, ePHD1 domain", "id": "IPR041961", "short_desc": "KMT2D_ePHD1"}, {"desc": "KMT2D, ePHD2 domain", "id": "IPR041964", "short_desc": "KMT2D_ePHD2"}, {"desc": "SET domain superfamily", "id": "IPR046341", "short_desc": "SET_dom_sf"}, {"desc": "KMT2D, PHD5 domain", "id": "IPR046999", "short_desc": "KMT2D_PHD5"}, {"desc": "KMT2D, PHD3 domain", "id": "IPR047000", "short_desc": "KMT2D_PHD3"}], "ipi": ["IPI00297859", "IPI00377245", "IPI01022092"], "map_location": "12q13.12", "name": "lysine methyltransferase 2D", "other_names": ["ALL1-related protein", "Kabuki make-up syndrome", "histone-lysine N-methyltransferase 2D", "histone-lysine N-methyltransferase MLL2", "lysine (K)-specific methyltransferase 2D", "lysine N-methyltransferase 2D", "myeloid/lymphoid or mixed-lineage leukemia 2", "trinucleotide repeat containing 21"], "pantherdb": {"HGNC": "7133", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "2682319", "ortholog_type": "LDO", "panther_family": "PTHR45888", "taxid": 10090, "uniprot_kb": "Q6PDK2"}, {"Ensembl": "ENSGALG00000031702", "ortholog_type": "LDO", "panther_family": "PTHR45888", "taxid": 9031, "uniprot_kb": "A0A1D5PV10"}, {"WormBase": "WBGene00011729", "ortholog_type": "O", "panther_family": "PTHR45888", "taxid": 6239, "uniprot_kb": "G5EGI1"}, {"FlyBase": "FBgn0263667", "ortholog_type": "O", "panther_family": "PTHR45888", "taxid": 7227, "uniprot_kb": "Q9W1H0"}], "uniprot_kb": "O14686"}, "pathway": {"kegg": [{"id": "hsa00310", "name": "Lysine degradation - Homo sapiens (human)"}, {"id": "hsa04934", "name": "Cushing syndrome - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-195721", "name": "Signaling by WNT"}, {"id": "R-HSA-201681", "name": "TCF dependent signaling in response to WNT"}, {"id": "R-HSA-201722", "name": "Formation of the beta-catenin:TCF transactivating complex"}, {"id": "R-HSA-212165", "name": "Epigenetic regulation of gene expression"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-3214841", "name": "PKMTs methylate histone lysines"}, {"id": "R-HSA-3247509", "name": "Chromatin modifying enzymes"}, {"id": "R-HSA-3769402", "name": "Deactivation of the beta-catenin transactivating complex"}, {"id": "R-HSA-4839726", "name": "Chromatin organization"}, {"id": "R-HSA-5617472", "name": "Activation of anterior HOX genes in hindbrain development during early embryogenesis"}, {"id": "R-HSA-5619507", "name": "Activation of HOX genes during differentiation"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-8878171", "name": "Transcriptional regulation by RUNX1"}, {"id": "R-HSA-8936459", "name": "RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function"}, {"id": "R-HSA-9772755", "name": "Formation of WDR5-containing histone-modifying complexes"}], "wikipathways": [{"id": "WP2369", "name": "Histone Modifications"}, {"id": "WP4949", "name": "16p11.2 proximal deletion syndrome"}]}, "pdb": ["3UVK", "4ERQ", "4Z4P", "6O7G"], "pfam": ["PF00628", "PF00856", "PF05964", "PF05965", "PF13771", "PF13832"], "pharmgkb": "PA30846", "pharos": {"target_id": 10724, "tdl": "Tbio"}, "pir": ["T03454", "T03455"], "prosite": ["PS50016", "PS50089", "PS50280", "PS50868", "PS51542", "PS51543", "PS51805"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF193807", "relationship": "is"}, {"id": "GNF218081", "relationship": "is"}, {"id": "GNF258315", "relationship": "is"}, {"id": "GNF258316", "relationship": "is"}, {"id": "GNF258317", "relationship": "is"}, {"id": "GNF258318", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF086261", "relationship": "is"}, {"id": "GNF086262", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051341", "relationship": "is"}, {"id": "GNF060828", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF068755", "relationship": "is"}, {"id": "GNF068756", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF099533", "relationship": "is"}, {"id": "GNF108675", "relationship": "similar to"}, {"id": "GNF139188", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000012.12", "NC_060936.1", "NG_027827.1"], "protein": "NP_003473.3", "rna": "NM_003482.4", "translation": {"protein": "NP_003473.3", "rna": "NM_003482.4"}}, "reporter": {"HG-U133_Plus_2": ["211790_s_at", "216845_x_at", "227527_at", "227528_s_at", "231974_at"], "HG-U95Av2": ["31507_at", "38165_s_at", "38166_r_at"], "HTA-2_0": ["TC12002349.hg.1", "TC12003277.hg.1"], "HuEx-1_0": "3453592", "HuGene-1_1": "7962951", "HuGene-2_1": "16764160"}, "retired": [3826, 27318], "summary": "The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010].", "symbol": "KMT2D", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1334512"}, "unigene": "Hs.731384", "uniprot": {"Swiss-Prot": "O14686", "TrEMBL": ["Q6PIA1", "Q59FG6", "A0A8I5KQT2", "A0A8I5KQD6", "A0A8I5KU18", "A0A8I5KSG1", "A0A8I5KQ09", "A0A804HJB5", "A0A8I5KYU5", "A0A8I5QKN1", "A0A8I5QJD5", "A0A8I5QJ79", "A0A8I5KU33", "A0A8I5KPB7", "A0A8I5QKP3", "A0A8I5KX79", "A0A8I5KU95", "A0A8I5QJA0", "A0A8I5QJD3", "A0A3B3ISC8", "A0A8I5KTR4", "A0A804HHR9", "A0A8I5QJE4", "A0A8I5KNS6", "A0A8I5KRH2"]}, "wikipedia": {"url_stub": "MLL2"}}